Skip to main content

Charles River Laboratories balance sheet

  • CRL · NYSE
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$337.97−0.83%Close 13 Nov 2026 · Market value $16.04B

At the end of fiscal 2025 (the year to 27 Dec 2025), Charles River Laboratories reported total assets of $7.14B, $213.8M in cash and equivalents, $2.63B of total debt; shareholders' equity was $3.16B.

From Charles River Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 27 Dec 2025.

Annual

Charles River Laboratories balance sheet, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$243.6M$182.6M$179.2M$68.91M$109.7M$155.9M$160.0M$117.9M$117.6M$163.8M$195.4M$238.0M$228.4M$241.2M$233.9M$276.8M$194.6M$213.8M
Short-term investments——$9.83M$5.36M$6.78M$11.16M—$20.52M$3.77M$28.49M$885.0K$941.0K$1.02M$1.06M————
Cash and short-term investments$243.6M$182.6M$189.0M$74.26M$116.5M$167.1M$160.0M$138.5M$121.4M$192.3M$196.3M$239.0M$229.4M$242.3M$233.9M$276.8M$194.6M$213.8M
Accounts receivable—$190.1M$193.0M$184.8M$203.0M$220.6M$258.0M$270.1M$364.1M$430.0M$472.2M$514.0M$617.7M$642.9M$752.4M$780.4M$720.9M$708.9M
Inventory—$102.7M$100.3M$92.97M$88.47M$89.40M$89.04M$93.73M$95.83M$115.0M$127.9M$160.7M$185.7M$199.1M$255.8M$380.3M$278.5M$299.1M
Current assets—$595.6M$552.9M$425.8M$485.3M$552.5M$579.3M$559.2M$656.8M$826.6M$897.8M$1.02B$1.20B$1.27B$1.44B$1.61B$1.40B$1.45B
Property, plant and equipment—$863.7M$752.7M$738.0M$717.0M$676.2M$676.8M$678.0M$755.8M$782.0M$932.9M$1.04B$1.12B$1.29B$1.47B$1.64B$1.60B$1.66B
Goodwill—$508.2M$198.4M$197.6M$208.6M$230.7M$321.1M$438.8M$787.5M$804.9M$1.25B$1.54B$1.81B$2.71B$2.85B$3.10B$2.85B$2.76B
Acquired intangibles—$153.6M$121.2M$93.44M$84.92M$84.54M$178.9M$280.8M$394.4M$369.8M$610.9M$689.4M$787.6M$1.06B$955.3M$864.1M$723.4M$340.0M
Long-term investments——$11.38M$11.05M$8.49M$17.91M$27.05M$32.73M——————————
Total assets—$2.20B$1.73B$1.56B$1.59B$1.63B$1.87B$2.07B$2.71B$2.93B$3.86B$4.69B$5.49B$7.02B$7.60B$8.20B$7.53B$7.14B
Accounts payable—$31.22M$30.63M$34.33M$31.22M$31.77M$33.81M$36.67M$68.48M$77.84M$66.25M$111.5M$122.5M$198.1M$205.9M$168.9M$140.3M$148.8M
Unearned revenue, current—$71.11M$66.91M$56.53M$56.42M$54.18M$78.12M$81.34M$127.7M$117.6M$145.1M$171.8M$207.9M$219.7M$264.3M$241.8M$248.3M$210.4M
Long-term debt · current portion—$35.41M$30.54M$14.73M$139.4M$21.24M$31.71M$15.19M$24.56M$28.55M$28.23M$35.55M$47.20M$101.0K$1.35M$3.17M$155.0K$166.0K
Current liabilities—$249.8M$259.8M$216.8M$342.2M$247.0M$294.7M$311.8M$429.6M$463.5M$558.2M$710.2M$839.8M$1.03B$1.09B$1.06B$994.1M$1.12B
Long-term debt · non-current—$457.4M$670.2M$703.2M$527.1M$641.8M$722.0M$821.0M$1.19B$1.09B$1.63B$1.85B$1.93B$2.66B$2.71B$2.65B$2.24B$2.14B
Operating lease liability———————————$136.6M$180.3M$286.2M$436.3M$474.1M$537.9M$491.7M
Finance lease liability———————————$30.53M$29.05M$27.22M$30.65M$28.55M$28.44M$27.88M
Total liabilities—$830.3M$1.04B$1.03B$983.1M$968.1M$1.17B$1.30B$1.86B$1.87B$2.52B$3.03B$3.35B$4.43B$4.58B$4.54B$4.02B$3.92B
Retained earnings—−$238.5M−$575.2M−$465.6M−$368.3M−$265.5M−$138.8M$10.54M$165.3M$288.7M$42.10M$280.3M$625.4M$980.8M$1.43B$1.89B$1.81B$1.39B
Minority interest—−$1.42M$1.30M$1.78M$2.40M$3.09M$3.72M$4.49M$2.36M$2.33M$2.45M$3.24M$3.57M$4.16M$4.79M$5.39M$5.45M$5.30M
Shareholders' equity$1.24B$1.38B$687.4M$525.6M$600.8M$641.0M$672.2M$733.1M$836.8M$1.05B$1.32B$1.63B$2.11B$2.53B$2.98B$3.60B$3.46B$3.16B
Total liabilities and equity—$2.20B$1.73B$1.56B$1.59B$1.63B$1.87B$2.07B$2.71B$2.93B$3.86B$4.69B$5.49B$7.02B$7.60B$8.20B$7.53B$7.14B
Total debt—$492.8M$700.8M$717.9M$666.4M$663.0M$753.8M$836.2M$1.21B$1.12B$1.65B$2.02B$2.16B$2.95B$3.15B$3.12B$2.78B$2.63B
Net debt—$310.3M$511.8M$643.6M$550.0M$496.0M$593.7M$697.8M$1.09B$928.3M$1.46B$1.78B$1.93B$2.71B$2.91B$2.85B$2.58B$2.41B
Net working capital—$163.3M$114.0M$140.1M$33.32M$149.6M$124.5M$129.5M$109.6M$199.3M$144.2M$73.13M$133.0M−$304.0K$113.5M$276.8M$214.4M$113.0M
Shares outstanding · period end—65.9M56.4M48.9M48.9M47.6M47.3M46.7M47.4M47.4M48.2M48.9M49.8M50.5M50.9M51.3M51.1M49.2M

Quarterly

Charles River Laboratories balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$276.8M$327.0M$179.2M$210.2M$194.6M$229.4M$182.8M$207.1M$213.8M$191.8M$192.0M$200.4M
Cash and short-term investments$276.8M$327.0M$179.2M$210.2M$194.6M$229.4M$182.8M$207.1M$213.8M$191.8M$192.0M$200.4M
Accounts receivable$780.4M$787.0M$762.2M$754.2M$720.9M$756.6M$767.6M$734.5M$708.9M$700.3M$711.8M$735.3M
Inventory$380.3M$361.3M$349.1M$336.2M$278.5M$290.2M$279.6M$302.6M$299.1M$359.7M$346.3M$319.6M
Current assets$1.61B$1.67B$1.50B$1.49B$1.40B$1.51B$1.47B$1.53B$1.45B$1.49B$1.53B$1.54B
Property, plant and equipment$1.64B———$1.60B$1.59B$1.61B$1.59B$1.66B$1.51B$1.49B$1.50B
Goodwill$3.10B$3.07B$3.08B$3.12B$2.85B$2.87B$2.94B$2.92B$2.76B$3.04B$3.08B$3.08B
Acquired intangibles$864.1M$827.6M$800.1M$778.5M$723.4M$655.7M$602.5M$571.1M$340.0M$249.0M$253.2M$238.7M
Total assets$8.20B$8.15B$7.95B$8.00B$7.53B$7.58B$7.56B$7.51B$7.14B$7.73B$7.53B$7.45B
Accounts payable$168.9M$129.7M$133.1M$136.0M$140.3M$149.3M$145.8M$169.6M$148.8M$134.0M$141.0M$144.5M
Unearned revenue, current$241.8M$256.4M$247.2M$252.0M$248.3M$250.5M$268.3M$237.7M$210.4M$194.3M$203.0M$204.2M
Long-term debt · current portion$3.17M$459.0K$435.0K$157.0K$155.0K$121.0K$98.00K$54.00K$166.0K$6.70M$5.46M$2.10M
Current liabilities$1.06B$954.8M$947.5M$1.01B$994.1M$1.05B$1.08B$1.12B$1.12B$1.09B$1.13B$1.09B
Long-term debt · non-current$2.65B$2.66B$2.41B$2.33B$2.24B$2.51B$2.33B$2.19B$2.14B$2.66B$2.62B$2.44B
Operating lease liability$474.1M———$537.9M———$491.7M———
Finance lease liability$28.55M$30.23M$29.64M$31.12M$28.44M$29.06M$28.55M$28.05M$27.88M$10.63M$9.85M$9.67M
Total liabilities$4.54B$4.45B$4.18B$4.18B$4.02B$4.34B$4.16B$4.06B$3.92B$4.74B$4.64B$4.18B
Retained earnings$1.89B$1.96B$2.05B$2.12B$1.81B$1.84B$1.89B$1.94B$1.39B$1.37B$1.37B$1.71B
Minority interest$5.39M$5.71M$4.29M$4.85M$5.45M$5.78M$6.31M$4.88M$5.30M$5.82M$6.35M$5.08M
Shareholders' equity$3.60B$3.64B$3.72B$3.78B$3.46B$3.19B$3.35B$3.41B$3.16B$2.94B$2.84B$3.23B
Total liabilities and equity$8.20B$8.15B$7.95B$8.00B$7.53B$7.58B$7.56B$7.51B$7.14B$7.73B$7.53B$7.45B
Total debt$3.12B$3.08B$2.84B$2.76B$2.78B$2.99B$2.79B$2.63B$2.63B$3.06B$3.03B$2.85B
Net debt$2.85B$2.75B$2.66B$2.55B$2.58B$2.76B$2.60B$2.42B$2.41B$2.87B$2.84B$2.65B
Net working capital$276.8M$386.3M$372.5M$272.3M$214.4M$225.9M$206.6M$203.1M$113.0M$203.3M$202.3M$245.4M
Shares outstanding · period end51.3M51.5M51.6M51.1M51.1M49.1M49.2M49.2M49.2M48.2M47.7M47.9M

The main figures as JSON and plain text. See data and methodology.

CRL in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.